Black Diamond Therapeutics, Inc.
BDTX
$1.60
$0.010.63%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 24.52M | 27.06M | 29.70M | 27.00M | 27.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 75.84M | 81.36M | 87.24M | 85.15M | 86.46M |
| Operating Income | -75.84M | -81.36M | -87.24M | -85.15M | -86.46M |
| Income Before Tax | -69.68M | -73.10M | -80.55M | -79.79M | -82.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -69.68 | -73.10 | -80.55 | -79.79 | -82.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -69.68M | -73.10M | -80.55M | -79.79M | -82.44M |
| EBIT | -75.84M | -81.36M | -87.24M | -85.15M | -86.46M |
| EBITDA | -75.49M | -81.02M | -86.87M | -84.74M | -86.02M |
| EPS Basic | -1.27 | -1.36 | -1.54 | -1.70 | -1.92 |
| Normalized Basic EPS | -0.78 | -0.87 | -0.98 | -1.09 | -1.21 |
| EPS Diluted | -1.27 | -1.36 | -1.54 | -1.70 | -1.92 |
| Normalized Diluted EPS | -0.78 | -0.87 | -0.98 | -1.09 | -1.21 |
| Average Basic Shares Outstanding | 220.08M | 215.11M | 209.54M | 190.91M | 175.58M |
| Average Diluted Shares Outstanding | 220.08M | 215.11M | 209.54M | 190.91M | 175.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |